As Michigan’s first end-to-end pharmacogenomics, or PGx, testing and analysis program, Blue Cross Personalized Medicine gives you the opportunity to keep your employees healthy and save on health care costs.
Every person processes medications in their own way. Their bodies may break down medications too slowly or too quickly, which can result in side effects or no effect at all.
Blue Cross Personalized MedicineSM can help your employees' health providers understand how they will respond to certain medications. It can target costly conditions, decrease medical claims and help reduce employee absences due to these medical conditions. The program is provided at no cost to you or your employees.
For the program, Blue Care Network has partnered with OneOme®, a precision medicine company co-founded by the Mayo Clinic. They can administer a test to give providers the genetic insights to identify a medication that can work best for your employee.
Read the latest news and information involving personalized medicine.MI Blues Perspectives
There are many ways personalization can improve the consumer experience. Which is why the applications of personalization are especially important in health care.Read more
For some drugs, researchers have discovered that genetic markers may influence treatment response. In those cases, PGx testing can be used to determine the right drug and dose for a patient.Read more
Blue Care Network members will soon have access to Michigan’s first end-to-end pharmacogenomics precision medicine program.Read more